Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia

BACKGROUND AND OBJECTIVE: Certain patients with heart failure (HF) are unable to tolerate spironolactone therapy due to hyperkalemia. Patiromer is a novel agent used to treat hyperkalemia and has been shown to be efficacious, safe, and well-tolerated. The potential clinical outcomes and economic val...

Descripción completa

Detalles Bibliográficos
Autores principales: Bounthavong, Mark, Butler, Javed, Dolan, Chantal M., Dunn, Jeffrey D., Fisher, Kathryn A., Oestreicher, Nina, Pitt, Bertram, Hauptman, Paul J., Veenstra, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244629/
https://www.ncbi.nlm.nih.gov/pubmed/30194623
http://dx.doi.org/10.1007/s40273-018-0709-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244629/
https://www.ncbi.nlm.nih.gov/pubmed/30194623
http://dx.doi.org/10.1007/s40273-018-0709-3

Ejemplares similares